S. Kuroki et al., Effects of cholestyramine on hepatic cholesterol 7 alpha-hydroxylase and serum 7 alpha-hydroxycholesterol in the hamster, LIPIDS, 34(8), 1999, pp. 817-823
Cholestyramine increases activities of hepatic cholesterol 7 alpha-hydroxyl
ase and serum levels of 7 alpha-hydroxycholesterol. To examine if serum 7 a
lpha-hydroxycholesterol levels parallel with enzyme activity, 0, 0.5, 1, 2,
4, and 10% of cholestyramine was administered to female golden Syrian hams
ters for 28 d in the dose-dependent study, and 2% cholestyramine for 0, 1,
3, 7, 14, 21, and 28 d in the time-dependent study. In the dose-dependent s
tudy, hepatic and serum cholesterol levels were significantly decreased dos
e-dependently when more than 0.5% of cholestyramine was fed for 28 d. Chole
styramine increased the cholesterol 7 alpha-hydroxylase activity in a dose-
dependent manner, while the serum 7 alpha-hydroxycholesterol level was esse
ntially unchanged. No correlation was found between the serum level and the
hepatic enzyme activity. In the time-dependent study, hepatic and serum ch
olesterol levels markedly decreased when 2% cholestyramine was fed for long
er than 3 d. The serum triglyceride level increased significantly for the f
irst 7 d and then decreased. Cholesterol 7 alpha-hydroxylase activity incre
ased significantly as early as day 1, reached maximum activity level on day
7, and then kept the significantly high values until day 28. The serum 7 a
lpha-hydroxycholesterol level significantly increased for the first 7 d and
decreased to the pretreatment level thereafter. 7 alpha-Hydroxycholesterol
levels significantly correlated with serum cholesterol and triglyceride le
vels. We conclude that the serum 7 alpha-hydroxycholesterol level does not
always reflect the activity of hepatic cholesterol 7 alpha-hydroxylase, whe
n cholesterol metabolism is severely disturbed by cholestyramine.